China's infant milk powder enterprises have to renew production licenses by May 31, and those who are unable to acquire new licenses will be asked to suspend production, says China Food and Drug Administration

Nevin Barich

Nevin Barich

BEIJING , May 29, 2014 () – China's infant milk powder enterprises have to renew their production licenses by May 31 and those who are unable to acquire new licenses will be asked to suspend production, according to the China Food and Drug Administration, reported by the Xinhua-run China Securities Journal.

Industry insiders predict that more than one third of the domestic infant milk powder companies will suspend production after the deadline for renewing licenses and they are likely to withdraw from the infant milk powder market. Currently, China has 127 licensed infant milk powder producers.

The country's infant milk powder market environment will be purified to some extent after the cut of production capacity but the competition between homegrown and foreign milk powder will remain furious, analysts say. (Edited by Liu Xiaoyun, liuxy08@xinhua.org)

(c) 2014 Xinhua News Agency

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.